User profiles for Barbara Mühlemann
Barbara MühlemannInstitute of Virology -- Charité Universitätsmedizin Berlin Verified email at charite.de Cited by 3051 |
Ancient hepatitis B viruses from the Bronze Age to the Medieval period
Hepatitis B virus (HBV) is a major cause of human hepatitis. There is considerable uncertainty
about the timescale of its evolution and its association with humans. Here we present 12 …
about the timescale of its evolution and its association with humans. Here we present 12 …
Diverse variola virus (smallpox) strains were widespread in northern Europe in the Viking Age
INTRODUCTION Variola virus (VARV), the causative agent of smallpox, is estimated to
have killed between 300 million and 500 million people in the 20th century and was …
have killed between 300 million and 500 million people in the 20th century and was …
[HTML][HTML] Human monkeypox–After 40 years, an unintended consequence of smallpox eradication
…, S Lule, J Maclennan, A McCollum, B Mühlemann… - Vaccine, 2020 - Elsevier
Smallpox eradication, coordinated by the WHO and certified 40 years ago, led to the cessation
of routine smallpox vaccination in most countries. It is estimated that over 70% of the world…
of routine smallpox vaccination in most countries. It is estimated that over 70% of the world…
Estimating infectiousness throughout SARS-CoV-2 infection course
INTRODUCTION Although post facto studies have revealed the importance of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission from presymptomatic, …
respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission from presymptomatic, …
[HTML][HTML] Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series
…, J Schneider, T Veith, B Mühlemann… - The Lancet Infectious …, 2020 - thelancet.com
Background In December, 2019, the newly identified severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, causing COVID-19, a respiratory …
coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, causing COVID-19, a respiratory …
[HTML][HTML] Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study
…, T Bleicker, ML Schmidt, B Mühlemann… - The Lancet …, 2021 - thelancet.com
Background Antigen point-of-care tests (AgPOCTs) can accelerate SARS-CoV-2 testing. As
some AgPOCTs have become available, interest is growing in their utility and performance. …
some AgPOCTs have become available, interest is growing in their utility and performance. …
[HTML][HTML] Defining the risk of SARS-CoV-2 variants on immune protection
The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants jeopardizes the protective antiviral immunity induced after infection or …
variants jeopardizes the protective antiviral immunity induced after infection or …
An analysis of SARS-CoV-2 viral load by patient age
As children are under-represented in current studies aiming to analyse transmission of
SARS-coronavirus 2 (SARS-CoV-2), their contribution to transmission is unclear. Viral load, as …
SARS-coronavirus 2 (SARS-CoV-2), their contribution to transmission is unclear. Viral load, as …
Mapping SARS-CoV-2 antigenic relationships and serological responses
During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic,
multiple variants escaping preexisting immunity emerged, causing reinfections of previously …
multiple variants escaping preexisting immunity emerged, causing reinfections of previously …
[HTML][HTML] Humoral immune escape by current SARS-CoV-2 variants BA. 2.86 and JN. 1, December 2023
LM Jeworowski, B Mühlemann, F Walper… - …, 2024 - eurosurveillance.org
Variant BA.2.86 and its descendant, JN.1, of SARS-CoV-2 are rising in incidence across
Europe and globally. We isolated recent JN.1, BA.2.86, EG.5, XBB.1.5 and earlier variants. We …
Europe and globally. We isolated recent JN.1, BA.2.86, EG.5, XBB.1.5 and earlier variants. We …